CLARUS VENTURES, LLC
CLARUS VENTURES, LLC is a Seed, Series A, Series B and Series C+ fund in the US writing $15M–$50M checks into biopharmaceutical, medical-device, diagnostics, therapeutics and oncology.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- biopharmaceutical, medical-device, diagnostics, therapeutics, oncology
- Check size
- $15M–$50M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2005
- Assets under management
- $1.7B
Thesis
Clarus Ventures is a life sciences venture capital firm founded in 2005, specializing in biopharmaceutical, medical device, and diagnostics sectors. Their investment thesis centers on companies developing breakthrough medicines for unmet medical needs, with a strategy that includes forging R&D-sharing and partnership arrangements to de-risk programs and accelerate development. They prioritize companies with breakthrough science or best-in-class assets, and have a significant focus on risk-sharing deals for late-stage clinical trials, particularly in oncology. The firm primarily invests in the United States, with offices in Cambridge, MA, and South San Francisco, CA. Their typical investment ranges from $15 million to $50 million per deal, with a focus on growth-stage companies. As of May 2026, they have approximately $1.7 billion in AUM.
Common questions
Does CLARUS VENTURES, LLC invest at the Seed stage?
Yes. CLARUS VENTURES, LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does CLARUS VENTURES, LLC write?
CLARUS VENTURES, LLC writes $15M–$50M checks.
Where does CLARUS VENTURES, LLC invest?
CLARUS VENTURES, LLC invests in the US.